All Stories

  1. Unraveling the biological potential of skin fibroblast: responses to TNF-α, highlighting intracellular signaling pathways and secretome
  2. Tissue-Specific Regulatory and Expression Patterns of CDG-causative genes account to Phenotypic Variability
  3. Immunopathology in PMM2-CDG: Defective glycosylation impact in the TNFα -TNFR1 signalling pathway
  4. Laminaria digitata Supplementation as a Climate-Smart Strategy to Counteract the Interactive Effects of Marine Heatwaves and Disease Outbreaks in Farmed Gilthead Seabream (Sparus aurata)
  5. An Injectable Thermoreversible Hydrogel Loaded with ManNAc for GNE Myopathy
  6. Isolation, Fixation and Characterization of Juvenile Gilthead Seabream Head Kidney Leukocytes by Flow Cytometry
  7. Beyond sialylation: Exploring the multifaceted role of GNE in GNE myopathy
  8. Advancing Non-Invasive Colorectal Cancer Screening: Exploring the Potential of Monoclonal Antibody L2A5
  9. Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition
  10. Decoding the Molecular Basis of the Specificity of an Anti-sTn Antibody
  11. New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells
  12. Mapping the diagnostic odyssey of congenital disorders of glycosylation (CDG): insights from the community
  13. A community-centric model for conference co-creation: the world conference on CDG for patients, families and professionals
  14. The role of sialoglycans in modulating dendritic cell function and tumour immunity
  15. Revisiting the immunopathology of congenital disorders of glycosylation: an updated review
  16. Cardiolipin Membranes Promote Cytochrome c Transformation of Polycyclic Aromatic Hydrocarbons and Their In Vivo Metabolites
  17. New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells
  18. Advancing cancer immunotherapy: from innovative preclinical models to clinical insights
  19. Altered expression of Sialyl Lewis X in experimental models of Parkinson’s disease
  20. Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes
  21. Congenital disorders of glycosylation (CDG): state of the art in 2022
  22. Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors
  23. Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer
  24. A Community-Based Participatory Framework to Co-Develop Patient Education Materials (PEMs) for Rare Diseases: A Model Transferable across Diseases
  25. Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals
  26. A Participatory Framework for Plain Language Clinical Management Guideline Development
  27. Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)
  28. Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective
  29. Concerted Regulation of Glycosylation Factors Sustains Tissue Identity and Function
  30. Oxidative Stress and Inflammatory Response of Skin Fibroblasts Exposed to Chlorpyrifos
  31. Editorial: Biomarkers in Genitourinary Cancers, Volume I
  32. Targeting Immune-Mediated Responses to Tackle GNE Myopathy
  33. Registered human trials addressing environmental and occupational toxicant exposures: Scoping review of immunological markers and protective strategies
  34. Use of Lipid Vesicles for Revealing the Potential Contribution of Cytochrome C in the Metabolism of Environmental Toxicants
  35. A Community-Led Approach as a Guide to Overcome Challenges for Therapy Research in Congenital Disorders of Glycosylation
  36. Comparison of Laccases and Hemeproteins Systems in Bioremediation of Organic Pollutants
  37. The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ)
  38. A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy
  39. Structural Insights in Mammalian Sialyltransferases and Fucosyltransferases: We Have Come a Long Way, but It Is Still a Long Way Down
  40. Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer
  41. Artificial Intelligence in Epigenetic Studies: Shedding Light on Rare Diseases
  42. Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis
  43. L1CAM as an E-selectin Ligand in Colon Cancer
  44. International consensus guidelines for phosphoglucomutase 1 deficiency ( PGM1‐CDG ): Diagnosis, follow‐up, and management
  45. New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach
  46. Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers
  47. Functional and Physiological Methods of Evaluating Median Nerve Regeneration in the Rat
  48. MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells
  49. Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?
  50. Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer
  51. CDG and immune response: From bedside to bench and back
  52. BD-2 and BD-3 increase skin flap survival in a model of ischemia and Pseudomonas aeruginosa infection
  53. Unconventional Perfusion Flaps in the Experimental Setting
  54. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up
  55. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications
  56. Application of Hyperthermia for Cancer Treatment: Synthesis and Characterization of Magnetic Nanoparticles and their internalization on Tumor Cell Lines
  57. International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up
  58. Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review
  59. Tools for the Screening of Sarcopenia: A Head-to-Head Comparison by the NOVA SarcoAging Group
  60. A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer
  61. Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
  62. Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids
  63. Ligation of the CD44 Glycoform HCELL on Culture-Expanded Human Monocyte-Derived Dendritic Cells Programs Transendothelial Migration
  64. Halilectin-3, a Lectin from the Marine Sponge Haliclona caerulea, Induces Apoptosis and Autophagy in Human Breast Cancer MCF7 Cells Through Caspase-9 Pathway and LC3-II Protein Expression
  65. Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease
  66. Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue
  67. CDG Therapies: From Bench to Bedside
  68. Reconstruction of a 10-mm-long median nerve gap in an ischemic environment using autologous conduits with different patterns of blood supply: A comparative study in the rat
  69. Antibacterial activity of a new lectin isolated from the marine sponge Chondrilla caribensis
  70. Dithiothreitol-based protein equalization technology to unravel biomarkers for bladder cancer
  71. Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1
  72. Correction: Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases
  73. Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods
  74. Structural characterization of two isolectins from the marine red alga Solieria filiformis (Kützing) P.W. Gabrielson and their anticancer effect on MCF-7 breast cancer cells
  75. E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy
  76. Green synthesis and structural characterization of completely decomposed granite (CDG) based geopolymer
  77. An Electronic Questionnaire for Liver Assessment in Congenital Disorders of Glycosylation (LeQCDG): A Patient-Centered Study
  78. Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation and ERK1/2 and p38 MAPK activation
  79. Reconstruction of a long defect of the ulnar artery and nerve with an arterialized neurovenous free flap in a teenager: A case report and literature review
  80. Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation
  81. Blood Supply to the Integument of the Abdomen of the Rat: A Surgical Perspective
  82. Optimization of an Arterialized Venous Fasciocutaneous Flap in the Abdomen of the Rat
  83. Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases
  84. Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology
  85. Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage
  86. Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature
  87. A Model of Free Tissue Transfer: The Rat Epigastric Free Flap
  88. Glycosyltransferase inhibitors: a promising strategy to pave a path from laboratory to therapy
  89. Bioactivity gradients of cytoprotective and anticancer catechins in skin: Simulation studies for the design of controlled release systems
  90. Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions
  91. Vaccine and Antibody Therapy Against Thomsen- Friedenreich Tumor-Associated Carbohydrate Antigens
  92. Systematic Review and Meta-Analysis of Unconventional Perfusion Flaps in Clinical Practice
  93. Immunological aspects of congenital disorders of glycosylation (CDG): a review
  94. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses
  95. In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex
  96. Immature myeloid cells and tolerogenic cytokine profile in lung adenocarcinoma metastatic lymph nodes assessed by endobronchial ultrasound
  97. Challenges in Antibody Development against Tn and Sialyl-Tn Antigens
  98. Protein disulfide isomerases: Impact of thapsigargin treatment on their expression in melanoma cell lines
  99. Characterization of antiproliferative potential and biological targets of a copper compound containing 4′-phenyl terpyridine
  100. Sweet side of bladder cancer
  101. Characterization of the antiproliferative potential and biological targets of a trans ketoimine platinum complex
  102. Abstract 3163: Transendothelial migration of uveal melanoma cells
  103. Meeting report on EMBO Workshop: Glycobiology and glycochemistry, applications to human health and disease
  104. Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells
  105. Intravital microscopy technique to study parasite dynamics in the labyrinth layer of the mouse placenta
  106. FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer
  107. Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines
  108. Cytokeratin 19, Carcinoembryonic Antigen, and Epithelial Cell Adhesion Molecule Detect Lung Cancer Lymph Node Metastasis in Endobronchial Ultrasound-Guided Transbronchial Aspiration Samples
  109. Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy
  110. Overexpression of tumour-ssociated carbohydrate antigen sialyl-Tn in advanced bladder tumours
  111. Diagnostic value of endobronchial and endoscopic ultrasound-guided fine needle aspiration for accessible lung cancer lesions after non-diagnostic conventional techniques: a prospective study
  112. The phagocytic capacity and immunological potency of human dendritic cells is improved by α2,6‐sialic acid deficiency
  113. Biological targets of new metal compounds
  114. Dendritic Cells: A Spot on Sialic Acid
  115. Sialyl-Tn in Cancer: (How) Did We Miss the Target?
  116. Postprandial Insulin Resistance in Zucker Diabetic Fatty Rats is Associated with Parasympathetic‐Nitric Oxide Axis Deficiencies
  117. Bladder cancer–glycosylation insights
  118. Sialylation and dendritic cells: bridging innate and adaptive immune responses
  119. Understanding Postprandial Glucose Clearance by Peripheral Organs: The Role of the Hepatic Parasympathetic System
  120. The Role of Sugars in Dendritic Cell Trafficking
  121. Sialyl Lewisx-dependent binding of human monocyte-derived dendritic cells to selectins
  122. Screening of congenital cytomegalovirus infection by real-time PCR in urine pools
  123. Abstract 377: Multifunctional magnetic nanoparticles for theranostic applications
  124. IL-4 and TNF-α Polymorphisms Are Associated with Risk of Multiple Superficial Tumors or Carcinoma in situ Development
  125. Effects of Bevacizumab on Autocrine VEGF Stimulation in Bladder Cancer Cell Lines
  126. Human dendritic cells contain cell surface sialyltransferase activity
  127. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines
  128. Efficacy of Bacille Calmette-Guérin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines
  129. Effect of sialic acid loss on dendritic cell maturation
  130. Regulatory cells, cytokine pattern and clinical risk factors for asthma in infants and young children with recurrent wheeze
  131. Surface α2-3- and α2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis
  132. Os factores genéticos da asma
  133. Sa.123. Sialylation on Human Monocyte-Derived Dendritic Cells
  134. Functional and Topological Analysis of the Burkholderia cenocepacia Priming Glucosyltransferase BceB, Involved in the Biosynthesis of the Cepacian Exopolysaccharide
  135. Studies on the Involvement of the Exopolysaccharide Produced by Cystic Fibrosis-Associated Isolates of the Burkholderia cepacia Complex in Biofilm Formation and in Persistence of Respiratory Infections
  136. Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide
  137. Sphingomonas paucimobilis beta-glucosidase Bgl1: a member of a new bacterial subfamily in glycoside hydrolase family 1
  138. Cloning and sequence analysis of the ces10 gene encoding a Sphingomonas paucimobilis esterase
  139. Gellan gum biosynthesis in Sphingomonas paucimobilis ATCC 31461: Genes, enzymes and exopolysaccharide production engineering
  140. Biochemical characterization of the β-1,4-glucuronosyltransferase GelK in the gellan gum-producing strain Sphingomonas paucimobilis A.T.C.C. 31461
  141. Identification of the pgmG Gene, Encoding a Bifunctional Protein with Phosphoglucomutase and Phosphomannomutase Activities, in the Gellan Gum-Producing Strain Sphingomonas paucimobilis ATCC 31461